Abstract

OBJECTIVETo compare once daily with thrice daily tobramycin for treatment of Pseudomonas aeruginosainfection in patients with cystic fibrosis.DESIGN22 patients with cystic fibrosis, mean (SD) age 11 (3.4) years (range 5.6–19.3),...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call